DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic ...

Dexcom advanced the launch of Stelo, its over-the-counter product for non-insulin type 2 diabetes, pre-diabetes, and ...

As part of the provincial government’s recent Budget 2025 announcement, Dexcom G7 and Dexcom G6 CGM systems are now publicly covered for residents living with diabetes age 18-25 and those over ...

Meanwhile, the UK launch of Freestyle Libre 3 comes as rival real-time CGM player Dexcom received a European CE mark for its G7 device for people with diabetes aged two years and older.

The government of Saskatchewan has expanded public coverage for continuous glucose monitoring (CGM) systems. The expansion, which now provides full coverage for CGMs for young adults ages 18 to 25 and ...

Both companies also sell reimbursable prescription CGMs for type 1 and type 2 diabetes, respectively, the G7 and Libre 3 range ... annual growth rates (CAGR) of CGM devices for insulin-dependent ...